Latest News & Updates

President’s Medical Exam Includes Colorectal Cancer Screening

This morning, President Barack Obama completed his first routine periodic physical examination as President at the National Naval Medical Center in Bethesda, Maryland. The President’s exam included a colorectal cancer screening test. Dr. Jeff Kuhlman, a Navy captain and Physician to the President, Chief White House Physician and Director of the White House Medical Unit examined the President. Dr. Kuhlman, issued the following report following the exam:

“The President completed all age-appropriate screening tests, to include colorectal cancer screening. A CT-colonography was performed with normal results. Follow-up colorectal cancer screening is recommended in 5 years for routine colon cancer screening.”

Screening is just one important way to prevent colorectal cancer. Take a few minutes to read more about preventing colorectal cancer.

Posted by Catherine Knowles on February 28th, 2010
Posted in: Policy & Advocacy News | No Comments »
Tags: CT colonography, President Obama

WNC Colorectal Cancer Evidence Academy:From Prevention to Treatment

Spend a day learning about colorectal cancer prevention and treatment with a focus on its burden in western North Carolina.

The Western North Carolina Evidence Academy plans a full day conference on Friday, March 12, 2010 at the Lake Junaluska Conference Center to explore issues of screening and advances in colorectal cancer treatment.

There is no cost to attend, but registration is required. Registration deadline is March 5.

Physicians, physician assistants, nurse practitioners, nurses, survivors and caregivers in Western North Carolina are invited to participate. CMEs and CEUs are available at no cost. Continue reading…

Posted by Kate Murphy on February 27th, 2010
Posted in: Research & Treatment News | No Comments »
Tags: colorectal cancer awareness, Colorectal Cancer Awareness Month, conferences

C3 Advocate Suzanne Lindley Testifies at House Hearing

C3 advocate Suzanne Lindley testified at a House Energy and Commerce Subcommittee on Health hearing entitled “Medical Radiation: An Overview of the Issues” on Friday, February 26, 2010. The Subcommittee held the hearing to examine the potential benefits and risks of the use of radiation in medicine.

Suzanne spoke eloquently about how radiation therapies have allowed her to live and thrive with cancer. She told the Subcommittee Members her story of hope and survival made possible by medical imaging technology and advances in radiation therapy.

Posted by Catherine Knowles on February 26th, 2010
Posted in: Policy & Advocacy News, Research & Treatment News | 2 Comments »
Tags: House Energy and Commerce Subcommittee on Health, Medical Imaging Technology, Radiation, Suzanne Lindley

Health Care Reform Summit at Blair House

At 10am (eastern) this morning, the President will host a bipartisan meeting at the Blair House to discuss health reform legislation. The meeting will be broadcast live – C‑SPAN coverage begins at 9:45am ET on C‑SPAN3, C‑SPAN.org and C‑SPAN Radio. The entire meeting will also be streamed live on www.WhiteHouse.gov.

View a side-by-side comparison of the House-passed and Senate-passed bills here. View the President’s health reform proposal here. Continue reading…

Posted by Catherine Knowles on February 25th, 2010
Posted in: Policy & Advocacy News | No Comments »
Tags: Congress, Health Care Reform, President Obama

Stage II Recurrence Test Now Available

How likely is it that an individual colon cancer will return?

Stage II colon cancer patients have a tough time knowing how likely it is that their cancer will recur and making a decision about having chemotherapy after surgery.

A test is now on the market that can help with that decision. OncoType DX® Colon Assay analyzes 12 key genes from a tumor sample to produce a recurrence score that indicates how likely stage II colon cancer will return.

While OncoType DX Colon can’t predict whether chemotherapy will reduce the chance that cancer will come back, it can help patients and their doctors decide on chemotherapy in combination with other factors.

Posted by Kate Murphy on February 25th, 2010
Posted in: Research & Treatment News | No Comments »
Tags: Oncotype DX, recurrence risk, stage II colon cancer